Drug Studies
Forward Trial
A Safety, Tolerability, and Efficacy Study of ZIMISLECEL in Participants With Type 1 Diabetes
Who Can Participate
- Clinical history of T1D with greater than 5 years of duration of insulin dependence
Massachusetts General Hospital, Boston, MA
Multiple Other Sites
Effects of Ketosis on Brain Function
Effects of Ketosis on Brain Function in Patients with T1DM
Who Can Participate
- Between the ages of 18-40 years
- Diagnosed with T1D for at least 1 year
Boston Children's Hospital, Boston, MA
PERL-FENO STUDY
A Pilot Study of Fenofibrate to Prevent Kidney Function Loss in Type 1 Diabetes (PERL-FENO)
Joslin Diabetes Center, Boston, MA
Lahey Hospital and Medical Center, Burlington, MA
SUNY Upstate Medical University, Syracuse, NY
Repeat BCG Vaccinations
Repeat BCG Vaccinations For The Treatment of Pediatric Type 1 Diabetes
Who Can Participate
- Between the ages of 12- <18 at the time of study entry and <18 at the time of randomization
- Type 1 diabetic subjects treated with insulin and >24 months since diagnosis
Massachusetts General Hospital, Boston, MA
- The safety and scientific validity of a research study is the responsibility of the study investigators and the study sponsor.
- It is important to evaluate the risks and potential benefits of clinical studies and to talk to your health care provider(s) before participating in a study.